TY -的AU -康威,谢丽尔·莫斯利AU - Kelechi,特蕾莎修女J PY - 2017 DA - 2017/08/16 TI -数字健康成人糖尿病或高血压药物治疗依从性:一个综合审查乔- JMIR糖尿病SP - e20六世- 2 - 2 KW -数字医疗KW -药物依从性KW -长期护理模式KW -糖尿病KW -高血压AB -背景:优化管理慢性疾病,如2型糖尿病和高血压,通常包括处方药。药物依从性(MA)是自我管理的一个组成部分。通过数字健康-电子健康和移动健康进行优化可以增强患者意识和/或患者与提供者之间的沟通。用药依从性是影响50%-60%慢性成年人的主要问题。数字卫生是指电子卫生和移动卫生的统称，随着这些技术变得更容易获得，远程卫生服务越来越多地可作为改善服药依从性的辅助手段;与患者和提供者沟通;并为患者、家庭和社区提供教育。这项综合综述的目的是研究针对糖尿病或高血压成年人群的药物依从性的数字健康技术类型。方法:利用EBSCOhost、PubMed和Scopus的数据库进行综合综述。截至2016年9月，符合条件的研究必须用英语撰写，必须包含数字健康干预措施，以提高18岁或以上成年人对处方药的依从性，并且必须专注于糖尿病或高血压。 Results: Of the 337 located studies, 13 (3.9%) used a digital health intervention for medication adherence to prescribed medications for diabetes or hypertension and were assessed according to the Chronic Care Model. Conclusions: The 13 studies included in this review found no conclusive evidence of improved medication adherence using digital health interventions such as interactive voice response (IVR), short message service (SMS) text messaging, telemonitoring, and interactive software technology. Among the 13 studies were digital health interventions that foster medication adherence via one-way communication to the patient or two-way communication between the patient and health care provider for adjunct medication adherence strategies. More research is needed to determine which digital health interventions are most beneficial for individuals with diabetes or hypertension. SN - 2371-4379 UR - http://diabetes.www.mybigtv.com/2017/2/e20/ UR - https://doi.org/10.2196/diabetes.8030 UR - http://www.ncbi.nlm.nih.gov/pubmed/30291093 DO - 10.2196/diabetes.8030 ID - info:doi/10.2196/diabetes.8030 ER -